MedTrace Logo

Multicenter Validation of the PREDICT Score

NCT05078515 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 262

Last updated 2021-10-14

No results posted yet for this study

Summary

Even after adequate TME with grade III mesorectal grading, local recurrence remains a possible event. Several studies investigated different parameters and assessed their predictive power in regards to local recurrence after TME. These parameters included a variety of patient-related, tumor-related, and treatment-related factors. A recent meta-analysis reviewed the current literature for the predictors of local recurrence after TME for rectal cancer and developed a prognostic scoring system, the PREDICT score.

The present study aimed to validate the PREDICT scoring system by applying it to a prospective cohort of patients with rectal cancer who underwent curative TME in three

Conditions

Interventions

DIAGNOSTIC_TEST

PREDICT score

Predictive score for local recurrence after TME for rectal cancer that includes 8 parameters

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Sameh H Emile, M.D., FACS · Mansoura University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-01
Primary Completion
2018-12-31
Completion
2021-08-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05078515 on ClinicalTrials.gov